JPRN-UMIN000003948招募中2 期
Randomized phase II trial of UFT plus Cisplatin versus Pemetrexed plus Cisplatin combined with Concurrent Thoracic Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer. North Japan Lung Cancer Study Group Trial 1001 (NJLCG1001) - RDM PII UFT+CDDP+RT vs PEM+CDDP+RT NJLCG1001
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 84
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Clinically active interstitial pneumonia or pulmonary fibrosis, detectable on CT scan 2) Malignant pleural or pericardial effusion or ascites 3) Severe co-morbidities (ex. uncontrolled heart or lung or hepatic or renal disease or diabetes) 4) Regular use of corticosteroid (less than 2 weeks interval after cessation) 5) Pregnancy or lactation, or those who decline contraception 6) Contraindication with chemotherapy or radiotherapy 7) Active concomitant malignancy. Except carcinoma in situ or those who did not relapse 5-years or more 8) Those judged to be not suitable by the attending physician
研究者
相似试验
已完成
1 期
Phase I/II trial of 5-FU, cisplatin, and weekly paclitaxel in patients with esophageal cancerEsophageal cancerJPRN-UMIN000013627ippon Medical School Musashi Kosugi Hospital47
已完成
2 期
Trial Evaluating Adapted Chemotherapy in Patients With Squamous CarcinomaCancer of Head and NeckNCT04356170Groupe Oncologie Radiotherapie Tete et Cou105
招募中
2 期
A phaseII randomized trial of UFT for the patients completely resected pathological Breast cancerBreast cancerJPRN-UMIN000004586Ryukyu Breast Club140
已完成
2 期
A randomized phase II study comparing cisplatin + docetaxel with carboplatin + paclitaxel in patients with Stage III (N 2 positive) non-small-cell lung cancer who receive trimodality treatment consisting of chemoradiotherapy followed by surgery (OLCSG1601)previously untreated non-small-cell lung ccancer, stage III (N2 positive)JPRN-UMIN000024816Okayama Lung Cancer Study Group (OLCSG)80
已完成
2 期
A randomized phase II study of cisplatin+TS-1 versus cisplatin+docetaxel, with thoracic radiotherapy for locally advanced non-small cell lung cancer (TORG1018)on-small cell lung cancerJPRN-UMIN000005993Thoracic Oncology Research Group110